Resumen de Intraperitoneal Chemotherapy for Ovarian Cancer Improves Survival but may be Underused

Joan Zolot

• According to this study:

  * Intraperitoneal chemotherapy used in combination with iv chemotherapy increased three-year survival rates in women with stage III ovarian cancer, compared with iv chemotherapy alone.

  * But those receiving intraperitoneal and iv chemotherapy were more likely to need changes to their treatment regimen because of treatment-related toxicities than those receiving only iv chemotherapy.

  * Although the use of intraperi-toneal and iv chemotherapy together has increased over the past decade, fewer than half of eligible patients receive it.